[Research progress of survival predictive score in veno-arterial extracorporeal membrane oxygenation]

Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022 Feb;34(2):211-215. doi: 10.3760/cma.j.cn121430-20210429-00648.
[Article in Chinese]

Abstract

Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is an extracorporeal circulation technique that provides circulatory and oxygenation support, and it is currently used in the treatment of cardiogenic shock (CS), pulmonary embolism, cardiac arrest (CA), and other diseases. However, this technology is still associated with high complications and mortality. The use of predictive scores for risk stratification before VA-ECMO will be helpful to screen the optimal benefiting population, make optimal clinical decisions, and allocate medical resources reasonably. At present, there are few reports about predictive scores for VA-ECMO. This article systematically reviewed the predictive performance of various scoring tools [the survival after venoarterial ECMO (SAVE) score, prediction of cardiogenic shock outcome for acute myocardial infarction (AMI) patients salvaged by VA-ECMO (ENCOURAGE) score, model for end-stage liver disease (MELD-XI) score, post-cardiotomy extracorporeal membrane oxygenation (PC-ECMO) score, the predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting (REMEMBER) score, predictors of mortality with VA-ECMO for acute massive pulmonary embolism, extracorporeal cardiopulmonary resuscitation (ECPR) score, the hypothermia outcome prediction after extracorporeal life support (HOPE) score] for patients receiving VA-ECMO to provide reference for clinical treatment.

MeSH terms

  • End Stage Liver Disease* / complications
  • Extracorporeal Membrane Oxygenation* / methods
  • Humans
  • Pulmonary Embolism* / complications
  • Retrospective Studies
  • Severity of Illness Index
  • Shock, Cardiogenic / therapy